157 related articles for article (PubMed ID: 25896312)
1. Long-term side effects of radiotherapy for pediatric localized neuroblastoma : results from clinical trials NB90 and NB94.
Ducassou A; Gambart M; Munzer C; Padovani L; Carrie C; Haas-Kogan D; Bernier-Chastagner V; Demoor C; Claude L; Helfre S; Bolle S; Leseur J; Huchet A; Rubie H; Valteau-Couanet D; Schleiermacher G; Coze C; Defachelles AS; Marabelle A; Ducassou S; Devalck C; Gandemer V; Munzer M; Laprie A;
Strahlenther Onkol; 2015 Jul; 191(7):604-12. PubMed ID: 25896312
[TBL] [Abstract][Full Text] [Related]
2. Intensity modulated radiation therapy provides excellent local control in high-risk abdominal neuroblastoma.
Pai Panandiker AS; Beltran C; Billups CA; McGregor LM; Furman WL; Davidoff AM
Pediatr Blood Cancer; 2013 May; 60(5):761-5. PubMed ID: 23024112
[TBL] [Abstract][Full Text] [Related]
3. Role of palliative radiotherapy in the management of metastatic pediatric neuroblastoma: a retrospective single-institution study.
Caussa L; Hijal T; Michon J; Helfre S
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):214-9. PubMed ID: 20382484
[TBL] [Abstract][Full Text] [Related]
4. Late effects of radiotherapy for pediatric extremity sarcomas.
Paulino AC
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):265-74. PubMed ID: 15337565
[TBL] [Abstract][Full Text] [Related]
5. Locoregional control in infants with neuroblastoma: role of radiation therapy and late toxicity.
Paulino AC; Mayr NA; Simon JH; Buatti JM
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1025-31. PubMed ID: 11958898
[TBL] [Abstract][Full Text] [Related]
6. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
[TBL] [Abstract][Full Text] [Related]
7. Proton radiotherapy for high-risk pediatric neuroblastoma: early outcomes and dose comparison.
Hattangadi JA; Rombi B; Yock TI; Broussard G; Friedmann AM; Huang M; Chen YL; Lu HM; Kooy H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1015-22. PubMed ID: 22138463
[TBL] [Abstract][Full Text] [Related]
8. Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1.
Rubie H; De Bernardi B; Gerrard M; Canete A; Ladenstein R; Couturier J; Ambros P; Munzer C; Pearson AD; Garaventa A; Brock P; Castel V; Valteau-Couanet D; Holmes K; Di Cataldo A; Brichard B; Mosseri V; Marquez C; Plantaz D; Boni L; Michon J
J Clin Oncol; 2011 Feb; 29(4):449-55. PubMed ID: 21172879
[TBL] [Abstract][Full Text] [Related]
9. Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective Trial.
Casey DL; Kushner BH; Cheung NV; Modak S; Basu EM; Roberts SS; LaQuaglia MP; Wolden SL
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):409-414. PubMed ID: 30763661
[TBL] [Abstract][Full Text] [Related]
10. Dose-escalation is needed for gross disease in high-risk neuroblastoma.
Casey DL; Kushner BH; Cheung NV; Modak S; LaQuaglia MP; Wolden SL
Pediatr Blood Cancer; 2018 Jul; 65(7):e27009. PubMed ID: 29469198
[TBL] [Abstract][Full Text] [Related]
11. Excellent local control from radiation therapy for high-risk neuroblastoma.
Gatcombe HG; Marcus RB; Katzenstein HM; Tighiouart M; Esiashvili N
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1549-54. PubMed ID: 19211198
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of therapy for stage C neuroblastoma.
Halperin EC
J Surg Oncol; 1996 Nov; 63(3):172-8. PubMed ID: 8944061
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of children with neuroblastoma receiving radiotherapy to metastatic lesions within the German Neuroblastoma Trials NB97 and NB 2004.
Jazmati D; Butzer S; Hero B; Doyen J; Ahmad Khalil D; Steinmeier T; Schulze Schleithoff S; Eggert A; Simon T; Timmermann B
Strahlenther Onkol; 2021 Aug; 197(8):683-689. PubMed ID: 33300099
[TBL] [Abstract][Full Text] [Related]
14. Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study.
Kohler JA; Rubie H; Castel V; Beiske K; Holmes K; Gambini C; Casale F; Munzer C; Erminio G; Parodi S; Navarro S; Marquez C; Peuchmaur M; Cullinane C; Brock P; Valteau-Couanet D; Garaventa A; Haupt R
Eur J Cancer; 2013 Nov; 49(17):3671-9. PubMed ID: 23907002
[TBL] [Abstract][Full Text] [Related]
15. Hyperfractionated low-dose (21 Gy) radiotherapy for cranial skeletal metastases in patients with high-risk neuroblastoma.
Kushner BH; Cheung NK; Barker CA; Kramer K; Modak S; Yataghene K; Wolden SL
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1181-6. PubMed ID: 19427746
[TBL] [Abstract][Full Text] [Related]
16. Percentage tumor necrosis following chemotherapy in neuroblastoma correlates with MYCN status but not survival.
Bomken S; Davies B; Chong L; Cole M; Wood KM; McDermott M; Tweddle DA
Pediatr Hematol Oncol; 2011 Mar; 28(2):106-14. PubMed ID: 21214410
[TBL] [Abstract][Full Text] [Related]
17. Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients.
Cozzarini C; Fiorino C; Deantoni C; Briganti A; Fodor A; La Macchia M; Noris Chiorda B; Rancoita PM; Suardi N; Zerbetto F; Calandrino R; Montorsi F; Di Muzio N
Eur Urol; 2014 Dec; 66(6):1024-30. PubMed ID: 24985964
[TBL] [Abstract][Full Text] [Related]
18. Acute and late side effects to salivary glands and oral mucosa after head and neck radiotherapy in children and adolescents. Results of the "Registry for the evaluation of side effects after radiotherapy in childhood and adolescence".
Bölling T; Weege J; Eich HT; Timmermann B; Meyer FM; Rübe C; Kortmann RD; Fischedick K; Rödel C; Koch R; Willich N
Head Neck; 2015 Aug; 37(8):1137-41. PubMed ID: 24764129
[TBL] [Abstract][Full Text] [Related]
19. High-dose chemotherapy followed by locoregional irradiation improves the outcome of patients with international neuroblastoma staging system Stage II and III neuroblastoma with MYCN amplification.
Laprie A; Michon J; Hartmann O; Munzer C; Leclair MD; Coze C; Valteau-Couanet D; Plantaz D; Carrie C; Habrand JL; Bergeron C; Chastagner P; Défachelles AS; Delattre O; Combaret V; Bénard J; Pérel Y; Gandemer V; Rubie H;
Cancer; 2004 Sep; 101(5):1081-9. PubMed ID: 15329919
[TBL] [Abstract][Full Text] [Related]
20. Tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk neuroblastoma: results of SMC NB-2004 study.
Sung KW; Son MH; Lee SH; Yoo KH; Koo HH; Kim JY; Cho EJ; Lee SK; Choi YS; Lim DH; Kim JS; Kim DW
Bone Marrow Transplant; 2013 Jan; 48(1):68-73. PubMed ID: 22635247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
